Vicarious Surgical Inc.
RBOT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.00 | -0.45 | -0.15 |
| FCF Yield | -64.73% | -120.31% | -25.59% | -3.37% |
| EV / EBITDA | -1.33 | -0.22 | -2.02 | -24.53 |
| Quality | ||||
| ROIC | -106.51% | -70.34% | -60.32% | -21.57% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.79 | 0.88 | -11.87 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 21.63% | 3.89% | -92.45% | -184.48% |
| Safety | ||||
| Net Debt / EBITDA | -0.07 | 0.55 | 1.27 | 4.95 |
| Interest Coverage | 0.00 | -3,226.64 | -400.39 | -429.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -201.99 | -247.66 | -325.68 | -1,732.59 |